NewBridge Pharmaceuticals Limited is a British Virgin Island domiciled company with its operating affiliate, NewBridge Pharmaceuticals FZ LLC (“NewBridge”), headquartered in Dubai, U.A.E.
NewBridge is a regional specialty company established to bridge the access gap and partner with global pharma and biotech companies to in-license and commercialize FDA or EMA/European approved innovative pharmaceutics, biologics, and other healthcare solutions in the Middle East and Africa regions (MENA). As such, NewBridge serves as a one-stop-solution for our partners, providing multi-country access across a wide region with growing economies but complex regulations and access hurdles.
The areas of Oncology, Immunology, Neuroscience, Gastrointestinal and Nutrition are NewBridge’s current strategic focus. The existing product portfolio was built to address unmet medical needs in the region and enabled the company not just to gain substantial market share but also to help patients gain access to these much needed medications. Future expansion includes providing our own branded products through the establishment of manufacturing and development capabilities.
NewBridge is driven by highly talented teams who come to us with a proven track record and in-depth experience in the pharmaceutical industry regionally and globally, which has allowed NewBridge to establish itself as a strategic pharmaceutical partner in the MENA Region.
NewBridgers are experienced, motivated and entrepreneurial, offering flexible partnership opportunities and best practices in the areas of commercial, regulatory, and medical affairs. In addition, we strive to provide the quality, performance and standards of compliance that pharmaceutical companies look for in a partner to serve as an extension of their practices and values in commercializing their products in the local markets. Furthermore, the team is well connected to a wide range of partners and key stakeholders both inside and outside of the region.
NewBridge is well backed by strong institutional and corporate investors who provide us with the extensive life science network and diverse investment expertise needed to further our shared mission of investing in healthcare, and building a platform of successful alliances in the region. This integrated strategy of regional expertise and strong global business network make NewBridge unique in its offering and well positioned to be the partner-of-choice for pharmaceutics, biotechnology and other healthcare companies seeking access to the rapidly growing markets of Middle East & Africa.